PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Glaviano A, Foo ASC, Lam HY et al. · 2023

Read PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer by Glaviano A, Foo ASC, Lam HY et al. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10436543.txt.

Description

Glaviano, Foo, Lam, and co-authors review a key cell pathway known as PI3K, AKT, and mTOR, often shortened to PAM. Healthy cells use this chain of signals to stay alive, grow, and divide at the right times. Signals from growth factors feed into the chain under tight control.

When control breaks down, the same pathway can help cancers grow and spread. The review explains how the chain works step by step, then surveys drugs built to block parts of it. Readers gain a clear map of a major cancer target and of the promise and limits of drugs aimed at it.

Catalog record

CREATORGlaviano A, Foo ASC, Lam HY et al.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE105 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPubMed Central

Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC10436543/

Browse the full library · About the Tower of Babel